Develop targeted evidence-generation plans that address critical business, regulatory, and clinical questions.
Real-world evidence has become a critical component of healthcare decision-making. Regulators, payers, providers, and patients increasingly expect evidence demonstrating how therapies perform in everyday clinical settings.
We evaluate:
Develop:
Generate evidence through:
Whether you need support with evidence generation, epidemiology, outcomes research, health economics, or advanced analytics, York HEOR Group is ready to help.
Identify, evaluate, and integrate the right data sources for your research objectives.
Conduct scientifically rigorous retrospective and prospective observational studies.
Demonstrate clinical and economic value to payers, health technology assessment bodies, and healthcare decision-makers.
It is evidence on how a medicine is used and performs in everyday practice. Pharma companies use it for regulatory submissions, market access, medical affairs, and publications.
It is the process of turning real-world data into evidence for a defined question: evidence gap assessment, study planning, protocol development, analysis, and publication.
Real-world data is the raw information collected in routine care. Real-world evidence is the insight produced by analyzing that data with a sound study design.
Claims studies of treatment patterns, electronic health record analyses comparing therapies, registry studies that follow patients over time, and burden of illness studies.
It complements trial results: it can describe the target population, inform trial design and endpoints, and show whether trial benefits hold in everyday practice.
Schedule a Consultation Today and learn how York HEOR Group can transform your healthcare data into evidence-driven decisions.